Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Buy
2,734
+29
+1% +$3.39K 0.03% 131
2026
Q1
$285K Hold
2,705
0.03% 142
2025
Q4
$285K Buy
2,705
+37
+1% +$3.47K 0.03% 155
2025
Q3
$211K Buy
2,668
+19
+0.7% +$1.56K 0.02% 142
2025
Q2
$238K Buy
2,649
+15
+0.6% +$1.19K 0.03% 147
2025
Q1
$262K Buy
2,634
+14
+0.5% +$1.31K 0.03% 132
2024
Q4
$298K Buy
2,620
+11
+0.4% +$1.13K 0.04% 122
2024
Q3
$323K Buy
2,609
+11
+0.4% +$1.31K 0.04% 100
2024
Q2
$343K Hold
2,598
0.05% 98
2024
Q1
$343K Buy
2,598
+11
+0.4% +$1.36K 0.05% 99
2023
Q4
$282K Buy
2,587
+21
+0.8% +$2.18K 0.04% 113
2023
Q3
$296K Hold
2,566
0.05% 100
2023
Q2
$296K Buy
2,566
+20
+0.8% +$2.27K 0.05% 105
2023
Q1
$283K Buy
+2,546
New +$275K 0.05% 102
2022
Q4
Sell
-2,534
Closed -$218K 118
2022
Q3
$218K Buy
2,534
+11
+0.4% +$982 0.04% 98
2022
Q2
$230K Buy
+2,523
New +$224K 0.04% 94
2021
Q1
Sell
-2,594
Closed -$202K 88
2020
Q4
$202K Buy
+2,594
New +$198K 0.04% 77

Other funds holding MRK

KWB Wealth's MRK Position: Q2 2026 in Review

KWB Wealth increased its Merck (MRK) stake by 1.1% in Q2 2026, buying an estimated $3.39K and bringing the position to 2,734 shares worth $351K. The position accounts for 0.03% of the portfolio, ranked #131.

KWB Wealth first reported a position in MRK in Q4 2020 and has held it in 17 quarters since. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • KWB Wealth held 2,734 shares of Merck worth $351K as of Q2 2026.
  • KWB Wealth bought 29 Merck shares in Q2 2026, an estimated $3.39K.
  • Merck made up 0.03% of KWB Wealth's portfolio in Q2 2026, its #131 holding.
  • KWB Wealth first reported a position in Merck in Q4 2020 and has held it in 17 quarters since.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on KWB Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.